Skip to main content
TD

Tandem Diabetes Care

Tandem Diabetes Care, founded in 2006 and headquartered in San Diego, is a Nasdaq-listed medical device manufacturer of automated insulin delivery systems, including the Tandem Mobi and t:slim X2 pumps and Control-IQ+ technology.

Tandem Diabetes Care is a medical device manufacturer founded in 2006 that develops, manufactures, and sells automated insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in San Diego, California, and is publicly traded on Nasdaq. Its engineering work spans automated insulin delivery, predictive algorithms, insulin pump technology, continuous glucose monitoring integration, digital health, and medical device manufacturing.

The company's product line includes Tandem Mobi, an insulin pump system for automated insulin delivery, and the t:slim X2 insulin pump, which runs on Control-IQ+ technology. Control-IQ+ is a proprietary predictive algorithm with AutoBolus that automates insulin delivery to improve glucose control and simplify diabetes management; the company describes it as the only technology of its kind on the market.

Design and development follow a human-centered approach, with the stated aim of creating new possibilities for people living with insulin-dependent diabetes. The commitment extends beyond hardware to comprehensive support programs and services for healthcare providers and patients.

Open jobs